CHU de Nantes — Nantes, Pays de la Loire Region

What best describes you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of CHU de Nantes, compiled from the ClinicalTrials.gov public registry.

972

Registered studies

340

Active

205

Recruiting now

463

Completed

109

Stopped or withdrawn

Most-studied conditions

Follicular Lymphoma · Myotonic Dystrophy Type 1 (DM1) · Crohn's Disease · ALK-positive Non-small Cell Lung Cancer (NSCLC)

Recently updated registry entries

NCT03049189 — Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients (Active Not Recruiting)
NCT07157774 — Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated… (Recruiting)
NCT06834074 — Expanded Access Program of Neladalkib (NVL-655) for Patients With Advanced ALK+ NSCLC or… (Available)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 08, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.